Literature DB >> 35397401

A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions.

Le Guo1, Yaxian Zhou1, Xueqing Nie1, Zhongrui Zhang2, Zhen Zhang1, Chunrong Li1, Taobo Wang2, Weiping Tang3.   

Abstract

Proteolysis targeting chimera (PROTAC) is one of the most frequently used technologies for targeted protein degradation. PROTACs are composed of target protein ligand, E3 ligase ligand and a linker between them. Traditional methods for the development of PROTACs involve step-by-step synthesis and are time consuming. Herein, we report a platform for the rapid synthesis of PROTACs (Rapid-TAC) via a traceless coupling reaction between ortho-phthalaldehyde (OPA) motif on the ligand of targeting protein and an amine fucntional group on the commercially available partial PROTAC library that is composed of different E3 ligase ligands and various types and lengths of linkers. Under our optimized miniaturized conditions, the full PROTACs can be synthesized in a high throughput manner and the products can be directly used for screening without any further manipulations including purification. We demonstrated the utility of this platform by quickly identifying active degraders for androgen receptor (AR) and BRD4 with DC50 of 41.9 nM and 8.9 nM, respectively. It is expected that this Rapid-TAC platform can be easily extended to many other targets, thus lowering the barrier to access this novel modelity for small molecule drug discovery and faciliate structure activity relationship studies.
Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AR; BRD4; Degradation; PROTAC

Mesh:

Substances:

Year:  2022        PMID: 35397401      PMCID: PMC9106932          DOI: 10.1016/j.ejmech.2022.114317

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   7.088


  25 in total

1.  Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists.

Authors:  Chuangxing Guo; Angelica Linton; Susan Kephart; Martha Ornelas; Mason Pairish; Javier Gonzalez; Samantha Greasley; Asako Nagata; Benjamin J Burke; Martin Edwards; Natilie Hosea; Ping Kang; Wenyue Hu; Jon Engebretsen; David Briere; Manli Shi; Hovik Gukasyan; Paul Richardson; Kevin Dack; Toby Underwood; Patrick Johnson; Andrew Morell; Robert Felstead; Hidetoshi Kuruma; Hiroaki Matsimoto; Amina Zoubeidi; Martin Gleave; Gerrit Los; Andrea N Fanjul
Journal:  J Med Chem       Date:  2011-10-07       Impact factor: 7.446

2.  Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction.

Authors:  Xing Qiu; Ning Sun; Ying Kong; Yan Li; Xiaobao Yang; Biao Jiang
Journal:  Org Lett       Date:  2019-05-08       Impact factor: 6.005

3.  Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Authors:  K M Sakamoto; K B Kim; A Kumagai; F Mercurio; C M Crews; R J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Targeted protein degraders crowd into the clinic.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2021-04       Impact factor: 84.694

5.  Ortho-Phthalaldehyde (OPA)-based chemoselective protein bioconjugation and peptide cyclization.

Authors:  Qing Zhang; Yue Zhang; Xuechen Li
Journal:  Methods Enzymol       Date:  2020-05-04       Impact factor: 1.600

Review 6.  Drugging the 'undruggable' cancer targets.

Authors:  Chi V Dang; E Premkumar Reddy; Kevan M Shokat; Laura Soucek
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

7.  Traceless and Chemoselective Amine Bioconjugation via Phthalimidine Formation in Native Protein Modification.

Authors:  Chun Ling Tung; Clarence T T Wong; Eva Yi Man Fung; Xuechen Li
Journal:  Org Lett       Date:  2016-05-18       Impact factor: 6.005

8.  Reactions of orthophthalaldehyde with ammonia and 2-aminoethanol.

Authors:  Eliona Kulla; Petr Zuman
Journal:  Org Biomol Chem       Date:  2008-08-29       Impact factor: 3.876

9.  OPA-Based Bifunctional Linker for Protein Labeling and Profiling.

Authors:  Qing Zhang; Yue Zhang; Heng Liu; Hoi Yee Chow; Ruijun Tian; Yi Man Eva Fung; Xuechen Li
Journal:  Biochemistry       Date:  2019-10-29       Impact factor: 3.162

Review 10.  Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.

Authors:  Laura M Luh; Ulrike Scheib; Katrin Juenemann; Lars Wortmann; Michael Brands; Philipp M Cromm
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-30       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.